Company

MacuLogix, Inc.

MacuLogix, Inc., founded in 2008 in Harrisburg, US, develops diagnostic and therapeutic solutions for age-related macular degeneration.

About

MacuLogix, Inc. develops diagnostic devices and therapeutic solutions for age-related macular degeneration (AMD), used mainly by eye care professionals to detect and manage the disease. Founded in 2008 in Harrisburg, US, the company raised USD 37.740 mn in a Series D round led by Vivo Capital in July 2022, at a valuation of USD 69.969 mn. LumiThera, Inc. acquired the company in July 2022.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in